Blue you said
"the company is aware that the news about the Her2 is misinterpreted"
the news about HER2 is NOT misinterpreted, please let them go back to the filing and read how vague it was, it was more misrepresented than misinterpreted.
Having said that i do not believe we will have any appreciation in price as we approach end of year tax related selling i think the shorts will use this as well to put further pressure down (or might be an opportunity for them to cover)
We won't see any rise again until January, Maybe thats why January calls were being heavily bought last two weeks ?
The above guessing about price is in case we don't hear any MAJOR news, PETX approval is not Major
a mega deal or buy out or positive phase 3 that will be only positive news that will move this stock
As for posters at meetings, i personally attend 2 medical conferences every yer, it baffles me why some people on this board think that a poster at a meeting will have ANY effect on price. There are HUNDREDS of posters at these national meetings and they sometimes get no attention from attendees. Late breaking Phase 3 clinical trials is what everybody looks for and attends. Posters are hung in poster areas and people walk around reading titles sometimes stopping at a poster for more than a minute to read. so please lets just be realistic.
- ADXS has excellent potential
- ADXS is heavily manipulated
- ADXS still doesn't have an approved product
- ADXS in my opinion even at this stage (read above) is still undervalued
- ADXS has Excellent potential (i know that was point number one)
Good luck guys
I'm not selling a single share its boom or bust for me ... Who's with me :)